Research and experimental development on natural sciences and engineering
SALMO PHARMA AS
Revenue 2024
NOK 10.6m
Operating profit
NOK 7.3m
Equity
NOK 12.9m
Incorporated
2015
Share capital
NOK 100,000
Roles
Daglig lederBjørn-Inge Rikhardsen
Regnskapsfører
Revisor
Styrets lederBjørn-Inge Rikhardsen
StyremedlemBerit Anne Aas Rikhardsen
StyremedlemJonny Berfjord
VaramedlemOlav Kyrre Rikhardsen
VaramedlemIngebjørg Rikhardsen
VaramedlemGeir Ove Aaker
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| NORVET AS | 80.0% | 80.000000 | 2025 |
| ÅKERØYA AS | 20.0% | 20.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.